Warning value of bioactive molecule expression in surgical specimens for early recurrence and metastasis of colorectal cancer after laparoscopic surgery

GUO Junyu; LIAO Chilin; GUO Houji

doi:10.7619/jcmp.20244869

Journal of Clinical Medicine in Practice > 2025 > 29(2): 57-62. > DOI: 10.7619/jcmp.20244869

GUO Junyu, LIAO Chilin, GUO Houji. Warning value of bioactive molecule expression in surgical specimens for early recurrence and metastasis of colorectal cancer after laparoscopic surgery[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 57-62. DOI: 10.7619/jcmp.20244869

Citation:

PDF (995 KB)

Warning value of bioactive molecule expression in surgical specimens for early recurrence and metastasis of colorectal cancer after laparoscopic surgery

1.
Anorectal Department, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, 533000
2.
Cardiovascular Department, Baise People's Hospital, Baise, Guangxi, 533000

More Information

Received Date: October 15, 2024
Revised Date: December 23, 2024

Graphical Abstract

Abstract

Abstract

Objective
To explore the warning value of expression of phosphoglycerate mutase 1 (PGAM1), microRNA-433-3p (miR-433-3p) and cyclin-dependent kinase 1 (CDK1) in surgical specimens for early recurrence and metastasis after laparoscopic surgery for colorectal cancer (CRC).
Methods
Clinical materials of 120 patients with laparoscopic surgery for CRC were retrospectively analyzed. Based on the incidence status of recurrence and metastasis within one year after surgery, the patients were divided into recurrence group (n=31) and non-recurrence group (n=89). The clinical materials and the expression levels of PGAM1, miR-433-3p, and CDK1 in surgical specimens were compared between the two groups. Logistic regression analysis was conducted to explore the impacts of PGAM1, miR-433-3p and CDK1 on recurrence and metastasis after laparoscopic surgery for CRC. Receiver operating characteristic (ROC) curve was drawn to analyze the values of PGAM1, miR-433-3p and CDK1 alone as well as their combination for predicting recurrence andmetastasis after laparoscopic surgery, and external validation was performed.
Results
The levels of PGAM1 mRNA and CDK1 mRNA in the recurrence group were significantly higher than those in the non-recurrence group, while the level of miR-433-3p was significantly lower (P < 0.05). Logistic regression analysis showed that PGAM1 mRNA (OR=1.387, 95%CI, 1.025 to 1.877), miR-433-3p (OR=0.543, 95%CI, 0.319 to 0.924), and CDK1 mRNA (OR=1.353, 95%CI, 1.108 to 1.651) were all independent factors associated with recurrence and metastasis after laparoscopic surgery for CRC (P < 0.05). ROC curve analysis showed that the area under the curve (AUC) for the combined prediction of recurrence and metastasis after laparoscopic surgery for CRC by PGAM1 mRNA, miR-433-3p, and CDK1 mRNA was 0.904 (95%CI, 0.836 to 0.950), which was superior to the predictive performance of each indicator alone. Individual value prediction results indicated that CRC patients would experience early recurrence and metastasis after laparoscopic surgery under the condition of a diagnostic accuracy rate of 84.17%. External validation showed that the Kappa value between the combined prediction result and the actual clinical result was 0.864 (95%CI, 0.611 to 0.984), indicating good consistency.
Conclusion
The expression levels of PGAM1, miR-433-3p, and CDK1 in surgical specimens are all independent factors influencing early recurrence and metastasis after laparoscopic surgery for CRC patients, and their combined detection has high predictive value for postoperative recurrence and metastasis.
- phosphoglycerate mutase 1,
- microRNA-433-3p,
- cyclin dependent kinase 1,
- colorectal cancer,
- laparoscopic surgery,
- recurrence,
- metastasis,
- predictive value

FullText(HTML)

References (27)

References

[1]	SHIN A E, GIANCOTTI F G, RUSTGI A K. Metastatic colorectal cancer: mechanisms and emerging therapeutics[J]. Trends Pharmacol Sci, 2023, 44(4): 222-236. doi: 10.1016/j.tips.2023.01.003
[2]	DIJKSTRA E A, NILSSON P J, HOSPERS G A P, et al. Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial[J]. Ann Surg, 2023, 278(4): e766-e772. doi: 10.1097/SLA.0000000000005799
[3]	MAHMOUD N N. Colorectal cancer: preoperative evaluation and staging[J]. Surg Oncol Clin N Am, 2022, 31(2): 127-141. doi: 10.1016/j.soc.2021.12.001
[4]	LUO J Q, YANG T W, WU J, et al. Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1[J]. Cell Death Dis, 2023, 14(8): 502. doi: 10.1038/s41419-023-06007-4
[5]	ZHANG J, GUO Y H, MA Y R, et al. MiR-433-3p targets AJUBA to inhibit malignant progression of glioma[J]. Neuroimmunomodulation, 2022, 29(1): 44-54. doi: 10.1159/000518084
[6]	HAN Z T, JIA Q, ZHANG J, et al. Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis[J]. J Exp Clin Cancer Res, 2023, 42(1): 228. doi: 10.1186/s13046-023-02781-3
[7]	GUAN T M, LI M, SONG Y, et al. Phosphorylation of USP29 by CDK1 governs TWIST1 stability and oncogenic functions[J]. Adv Sci, 2023, 10(11): e2205873. doi: 10.1002/advs.202205873
[8]	中华医学会肿瘤学分会早诊早治学组. 中国结直肠癌早诊早治专家共识[J]. 中华医学杂志, 2020, 100(22): 1691-1698. doi: 10.3760/cma.j.cn112137-20190924-02103
[9]	IONESCU V A, GHEORGHE G, BACALBASA N, et al. Colorectal cancer: from risk factors to oncogenesis[J]. Medicina, 2023, 59(9): 1646. doi: 10.3390/medicina59091646
[10]	PATEL S G, KARLITZ J J, YEN T, et al. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection[J]. Lancet Gastroenterol Hepatol, 2022, 7(3): 262-274. doi: 10.1016/S2468-1253(21)00426-X
[11]	李忠发, 陈元龙, 李扬. 结直肠癌转录因子激活蛋白2α和2β表达与腹腔镜下根治术后复发的临床关系[J]. 中国内镜杂志, 2023, 29(11): 33-38.
[12]	HOU Y C, ZHANG X T, YAO H, et al. METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells[J]. EMBO Rep, 2023, 24(4): e56325. doi: 10.15252/embr.202256325
[13]	SUN X D, HE L F, LIU H, et al. The diapause-like colorectal cancer cells induced by SMC4 attenuation are characterized by low proliferation and chemotherapy insensitivity[J]. Cell Metab, 2023, 35(9): 1563-1579, e8. doi: 10.1016/j.cmet.2023.07.005
[14]	于文文, 李舒展, 王敏, 等. 磷酸甘油酸变位酶1在结直肠癌组织中的表达及其对患者预后和癌细胞恶性生物学行为的影响[J]. 中国肿瘤生物治疗杂志, 2023, 30(10): 862-867.
[15]	LIU M, LI R M, WANG M, et al. PGAM1 regulation of ASS1 contributes to the progression of breast cancer through the cAMP/AMPK/CEBPB pathway[J]. Mol Oncol, 2022, 16(15): 2843-2860. doi: 10.1002/1878-0261.13259
[16]	MATTHEWS H K, BERTOLI C, DE BRUIN R A M. Cell cycle control in cancer[J]. Nat Rev Mol Cell Biol, 2022, 23(1): 74-88. doi: 10.1038/s41580-021-00404-3
[17]	金熠蓉, 储屹, 吴开春, 等. Sec62对结直肠癌细胞的增殖作用及其潜在机制[J]. 空军军医大学学报, 2022, 43 (4): 309-314.
[18]	王国强, 张纲, 唐建坡, 等. SOX4通过靶向调节miR-17表达水平对结直肠癌细胞免疫逃逸及细胞迁移的影响[J]. 检验医学与临床, 2024, 21(13): 1825-1830.
[19]	WANG Q S, BODE A M, ZHANG T S. Targeting CDK1 in cancer: mechanisms and implications[J]. NPJ Precis Oncol, 2023, 7(1): 58. doi: 10.1038/s41698-023-00407-7
[20]	ZENG K X, LI W H, WANG Y, et al. Inhibition of CDK1 overcomes oxaliplatin resistance by regulating ACSL4-mediated ferroptosis in colorectal cancer[J]. Adv Sci, 2023, 10(25): e2301088. doi: 10.1002/advs.202301088
[21]	LIU F, ZHU C M, MA H, et al. Curcumin targets miR-134-5p to suppress the progression of colorectal cancer through regulating the CDCA3/CDK1 pathway[J]. Naunyn Schmiedebergs Arch Pharmacol, 2024, 397(1): 109-122. doi: 10.1007/s00210-023-02584-5
[22]	DING L, XU Y J, XU L, et al. Programmed cell death 11 modulates but not entirely relies on p53-HDM2 loop to facilitate G2/M transition in colorectal cancer cells[J]. Oncogenesis, 2023, 12(1): 57. doi: 10.1038/s41389-023-00501-2
[23]	LU P F, YU Z N, WANG K N, et al. DDX21 interacts with WDR5 to promote colorectal cancer cell proliferation by activating CDK1 expression[J]. J Cancer, 2022, 13(5): 1530-1539. doi: 10.7150/jca.69216
[24]	LOBERA E S, VARELA M A, JIMENEZ R L, et al. miRNA as biomarker in lung cancer[J]. Mol Biol Rep, 2023, 50(11): 9521-9527. doi: 10.1007/s11033-023-08695-9
[25]	QU J X, CHEN Q Y, BING Z Q, et al. C. tropicalis promotes CRC by down-regulating tumor cell-intrinsic PD-1 receptor via autophagy[J]. J Cancer, 2023, 14(10): 1794-1808. doi: 10.7150/jca.79664
[26]	MAO Z H, LIN D P, XU J. Hsa_circ_0001535 regulates colorectal cancer progression via the miR-433-3p/RBPJ axis[J]. Biochem Genet, 2023, 61(3): 861-878. doi: 10.1007/s10528-022-10287-4
[27]	白雨微, 黄小齐, 刘航, 等. 微小RNA-433-3p靶向调控RAP1A对结直肠癌细胞生物学行为的影响[J]. 临床肿瘤学杂志, 2022, 27(12): 1092-1098.

Cited By

Get Citation

PDF

XML

Article views (47) PDF downloads (5)

Turn off MathJax

Article Contents

Abstract

References

Warning value of bioactive molecule expression in surgical specimens for early recurrence and metastasis of colorectal cancer after laparoscopic surgery

Abstract

References

Catalog

Export File

Citation

Format

Content